The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice
about
Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrierAntitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cellsModulatory function of invariant natural killer T cells in systemic lupus erythematosusRelationships between Th1 or Th2 iNKT cell activity and structures of CD1d-antigen complexes: meta-analysis of CD1d-glycolipids dynamics simulationsNatural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitisOrgan-specific protective role of NKT cells in virus-induced inflammatory demyelination and myocarditis depends on mouse strain.A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in malesThe stimulating adventure of KRN 7000.Natural killer T cells and innate immune B cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodiesNKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and InflammationInvariant NKT Cell Lines Derived from the NOD·H2 Mouse Enhance Autoimmune Thyroiditis.Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent.Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupusDisparate effects of depletion of CD1d-reactive T cells during early versus late stages of disease in a genetically susceptible model of lupus.Brief treatment with iNKT cell ligand α-galactosylceramide confers a long-term protection against lupus.SLE: translating lessons from model systems to human diseaseThe role of invariant natural killer T cells in lupus and atherogenesisExamining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus modelA female preponderance for chemically induced lupus in SJL/J mice.Invariant natural killer T cells: bridging innate and adaptive immunity.Natural killer T cells in health and disease.Does the developmental status of Valpha14i NKT cells play a role in disease?Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity.Contrasting roles for Valpha14+ natural killer T cells in a viral model for multiple sclerosis.Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritisBeta-galactosylceramide alters invariant natural killer T cell function and is effective treatment for lupusInvariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens.Different subsets of natural killer T cells may vary in their roles in health and disease.A Solvent-free Approach to Glycosyl Amides: Towards the Synthesis of α-N-Galactosyl Ceramides.Slam haplotypes modulate the response to lipopolysaccharide in vivo through control of NKT cell number and functionIntrinsic hyporesponsiveness of invariant natural killer T cells precedes the onset of lupus.Decreased CD1d level is associated with CD86 over-expression in B cells from systemic lupus erythematosus.Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity.
P2860
Q24676227-C8CA9383-6CD5-4529-9CA9-36FE4600806DQ27003110-F9FDE0F0-7CDE-4325-BFCB-A044825CE7A3Q27010174-AB48ED95-7E80-4F10-A138-4E50336F790AQ27320844-31E3339D-EF2C-4F0D-BFAF-7A4D58CD16A0Q28085038-D640DFEA-EEE1-41F4-819C-7760BE0606C3Q30393778-4B2AEB2A-B214-4943-8378-4102CFF5EAB0Q33748552-F191BFE0-30D7-4095-B961-7F1CF0EDB8E3Q33843406-E63B5091-DA1C-4234-AA47-965DB15A76B8Q34043615-02F8D3E0-BDE0-4449-81C6-1C3242536931Q34288977-D2B4DB7C-3B69-42C9-A1F4-FB61B18C0EF0Q34985362-A3736AF1-DD85-49DF-97F8-FC9C56C56B4CQ35539166-FE1A45B5-000D-4010-80D0-7FD762543C80Q35593759-F1BEFB64-C6AC-482D-806F-A03C229AD8C6Q35854737-29EEC12C-F0F3-44CF-ABED-79D9869068D9Q36143507-19B59C66-A6C4-4B2E-B9BB-E66607523577Q36203872-BF8AE839-60B9-4D70-9309-BF9BFDF3D4D7Q36254076-F7AF6F5E-9EC0-4FD4-AD29-8DE1E65D1862Q36487076-CC2CA0F3-56EF-4FAA-B518-4EF45EC53288Q36536951-776522BE-61ED-439B-BBFE-8E416270A8D5Q36536962-F93EE145-F462-497E-9EAA-E8B92DED2599Q36739848-BB8E1BA3-704A-4B9F-9DE0-4C714FCB6EC9Q36765720-9370BF5A-AB1D-45B8-8F18-D4FAD105DCFCQ36799673-793A9B0C-AFC1-4080-AF43-A71F8847B7EFQ36799691-3CAE8DE0-CE1D-4C6D-990A-B84DAF5C7B4BQ36993238-D4F86E71-903D-473E-B99F-7A7BBA884985Q37165250-ABDC4258-C8D0-4A1A-9EB8-8F757494D1B4Q37211135-79D92659-7524-4995-97C9-8F007AD262E7Q37288170-766F325C-0915-4E19-88DD-B28A170DC3E4Q37822744-89A997C9-FA8F-4ED6-893F-4E3A3F988514Q38178734-D1367AC0-5DD9-4F47-9317-E5871B579392Q41165520-966FAE4D-B7BD-4039-94D4-FD90E89B1CC6Q42682436-103F15D2-59A2-435D-AFED-538A7D1BBA04Q46882098-0078888C-2DA8-4B2B-9AD5-3C449ADC35A3Q51088258-FBDB3B84-C06B-4129-B357-603F4326B333Q55280646-12FFB6AC-EF77-4F4E-8454-9B4D0F951011
P2860
The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The natural killer T cell liga ...... pristane-induced lupus in mice
@ast
The natural killer T cell liga ...... pristane-induced lupus in mice
@en
type
label
The natural killer T cell liga ...... pristane-induced lupus in mice
@ast
The natural killer T cell liga ...... pristane-induced lupus in mice
@en
prefLabel
The natural killer T cell liga ...... pristane-induced lupus in mice
@ast
The natural killer T cell liga ...... pristane-induced lupus in mice
@en
P2093
P2860
P356
P1476
The natural killer T cell liga ...... pristane-induced lupus in mice
@en
P2093
Avneesh K Singh
Chyung-Ru Wang
Jun-Qi Yang
Ram R Singh
Vrajesh V Parekh
P2860
P304
P356
10.1002/EJI.200425861
P407
P577
2005-04-01T00:00:00Z